1. Lyu, Tian-Jie, Ma, Ji, Zhang, Xi-Yin, Wang, Yun, Zhang, Hong-Quan. 2024. Deficiency of FRMD5 results in neurodevelopmental dysfunction and autistic-like behavior in mice. In Molecular psychiatry, 29, 1253-1264. doi:10.1038/s41380-024-02407-w. https://pubmed.ncbi.nlm.nih.gov/38228891/
2. Keller Sarmiento, Ignacio J, Bustos, Bernabe I, Blackburn, Joanna, Krainc, Dimitri, Mencacci, Niccolò E. 2024. De novo FRMD5 Missense Variants in Patients with Childhood-Onset Ataxia, Prominent Nystagmus, and Seizures. In Movement disorders : official journal of the Movement Disorder Society, 39, 1231-1236. doi:10.1002/mds.29791. https://pubmed.ncbi.nlm.nih.gov/38576116/
3. Gaweł, Agata M, Ratajczak, Maciej, Gajda, Ewa, Oczko-Wojciechowska, Małgorzata, Godlewska, Marlena. 2021. Analysis of the Role of FRMD5 in the Biology of Papillary Thyroid Carcinoma. In International journal of molecular sciences, 22, . doi:10.3390/ijms22136726. https://pubmed.ncbi.nlm.nih.gov/34201607/
4. Mao, Xiaowen, Tey, Sze Keong, Ko, Frankie Chi Fat, Guan, Xin-Yuan, Yam, Judy Wai Ping. 2018. C-terminal truncated HBx protein activates caveolin-1/LRP6/β-catenin/FRMD5 axis in promoting hepatocarcinogenesis. In Cancer letters, 444, 60-69. doi:10.1016/j.canlet.2018.12.003. https://pubmed.ncbi.nlm.nih.gov/30583072/
5. Guo, Tao, Yin, Rui-Xing, Pan, Ling, Miao, Liu, Huang, Feng. 2017. Integrative variants, haplotypes and diplotypes of the CAPN3 and FRMD5 genes and several environmental exposures associate with serum lipid variables. In Scientific reports, 7, 45119. doi:10.1038/srep45119. https://pubmed.ncbi.nlm.nih.gov/28332615/
6. Zhu, Chi, Yamaguchi, Kiyoshi, Ohsugi, Tomoyuki, Ikenoue, Tsuneo, Furukawa, Yoichi. 2017. Identification of FERM domain-containing protein 5 as a novel target of β-catenin/TCF7L2 complex. In Cancer science, 108, 612-619. doi:10.1111/cas.13174. https://pubmed.ncbi.nlm.nih.gov/28117551/
智鼠故事 
